skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About Patricia


+28 year(s) experience

Patricia Reilly Pharma_Intelligence
Patricia Reilly develops and maintains our partnerships with biotech and pharma organizations and societies. As a strategic partner and sponsor of these societies, she offers thought leadership, publications, and data access.

Patricia also writes for external partner publications, providing analysis as well as pharma and biotech sector reviews that examine scientific and financial growth. Previously, Patricia led the Citeline CNS, Autoimmune/Inflammation and Ophthalmology therapeutic area teams.


She was also given responsibility for the Medtrack database, which needed extensive editorial revamping and oversight. It has now become an industry-leading product. Before joining Informa in 2004, Patricia worked at Boehringer Ingelheim, first as a research scientist and later in competitive intelligence of the in-licensing group.

Analyst Articles

Articles by Patricia

  • Datamonitor Healthcare

    Trends in Gene Therapy Seminar

    By Patricia Reilly 22 Aug 2018

    The promises of gene therapy are taking a long time to be fulfilled, in part due to challenges in developing gene vectors capable of safe and efficient delivery of therapeutic genes (transgenes) into patients’ cells. Nonetheless, these challenges are being addressed in innovative ways. A variety of first-generation vectors, both viral and non-viral, have been employed in clinical trials with varying degrees of success, and the experience gained is guiding the design of next-generation vectors.